Also called: Iron overload disease
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Hemochromatosis
Hemochromatosis is a disease in which too much iron builds up in your body. Your body needs iron but too much of it is toxic. If you have hemochromatosis, you absorb more iron than you need. Your body has no natural way to get rid of the extra iron. It stores it in body tissues, especially the liver, heart, and pancreas. The extra iron can damage your organs. Without treatment, it can cause your organs to fail.
There are two types of hemochromatosis. Primary hemochromatosis is an inherited disease. Secondary hemochromatosis is usually the result of something else, such as anemia, thalassemia, liver disease, or blood transfusions.
Many symptoms of hemochromatosis are similar to those of other diseases. Not everyone has symptoms. If you do, you may have joint pain, fatigue, general weakness, weight loss, and stomach pain.
Your doctor will diagnose hemochromatosis based on your medical and family histories, a physical exam, and the results from tests and procedures. Treatments include removing blood (and iron) from your body, medicines, and changes in your diet.
It sits within Digestive System, Genetics/Birth Defects and Metabolic Problems.
The lead U.S. institute for this subject is the National Heart, Lung, and Blood Institute.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Hemochromatosis
87 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Treatment of HemochromatosisNational Institutes of Health Clinical Center (CC)
- Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary HemochromatosisCSL Behring
- Impact of Transferrin Saturation Guided Maintenance Treatment on Quality of Life in HFE HaemochromatosisRennes University Hospital
- A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary HemochromatosisBond Biosciences
- Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematopoietic Stem-Cell Transplantation.Assistance Publique - Hôpitaux de Paris
- Leflunomide for Idiopathic Pulmonary Hemosiderosis in ChildrenSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Research already completed
- Haemochromatosis and PeriodontitisRennes University Hospital
- Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary StudyRennes University Hospital
- Repeatability and Reproducibility of Multiparametric MRIPerspectum
- PTG-300 in Subjects With Hereditary HemochromatosisProtagonist Therapeutics, Inc.
- Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron ContentUniversity of Wisconsin, Madison
- Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-FranceCentre Hospitalier Sud Francilien
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- HemochromatosisNational Institute of Diabetes and Digestive and Kidney Diseases
- HemochromatosisAmerican Liver Foundation
- Hereditary HemochromatosisAmerican Academy of Family Physicians
Diagnosis and Tests
- Ferritin Blood TestNational Library of Medicine
- Iron TestsNational Library of Medicine
- Liver Function TestsNational Library of Medicine
Treatments and Therapies
- Iron ChelationAplastic Anemia and MDS International Foundation
Genetics
- About HemochromatosisNational Human Genome Research Institute
- Hereditary hemochromatosis: MedlinePlus GeneticsNational Library of Medicine
- Hypochromic microcytic anemia with iron overload: MedlinePlus GeneticsNational Library of Medicine
Clinical Trials
- ClinicalTrials.gov: HemochromatosisNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Hemochromatosis. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Hemochromatosis, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.